DTG

Dược phẩm Tipharco ·HNX ·2026Q1

▼ Slightly negative

Working capital is tied up too long in the operating cycle Working capital 175 days
Price
15,500
Latest close
01 Jun 2026
P/E 8.04x
P/B 0.73x
EPS 1,929
BVPS 21,331
ROE 9.4%
ROA 6.2%
Profit Margin 5.6%
Asset Turnover 1.11x
Equity Mult. 1.52x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DTG posted slightly lower profit versus the same period — an early signal that some factors are becoming less favorable — margins have been compressing consistently over multiple periods. What still needs to be determined is whether this is a temporary adjustment or an early sign of a weaker trend.

TTM REVENUE
VND 329bn
−7.4%YoY
NET MARGIN
5.61%
+0.2ppYoY
TTM NET PROFIT
VND 18bn
−3.6%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 70.7 124.1 68.7 65.9 58.3 148.4 66.0 82.9 66.7 131.0 73.6 78.3
Growth -43% +81% +4% +13% -61% +125% -20% +24% -49% +78% -6%
Net Income 6.0 11.3 0.9 0.3 0.3 10.1 3.0 5.7 4.3 13.6 3.9 3.9
Net Margin 8.52% 9.08% 1.33% 0.44% 0.60% 6.84% 4.53% 6.86% 6.46% 10.39% 5.29% 5.02%

Drivers of DTG's profit

TTM

Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:

Finance costs ↓ 2.1bn
Tax ↓ 0.6bn
Gross profit ↓ 1.9bn
Selling expenses ↑ 1.8bn
Financial income ↓ 0.3bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:

Gross profit ↑ 6.4bn
Administrative expenses ↓ 1.2bn
Finance costs ↓ 0.8bn
Tax ↑ 1.4bn
Selling expenses ↑ 1.2bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 10.7% = 5.4% × 1.12 × 1.78
2026Q1 9.4% = 5.6% × 1.11 × 1.52

ROE fell from 10.7% to 9.4% — leverage weakened the most, though net margin still provided support.

Net margin: 5.6% +0.2pp Asset turnover: 1.11x -0.01x Leverage: 1.52x -0.27x

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

very positive positive stable watch under pressure

What is driving the margin?

Net margin stands at 5.61%, broadly flat versus the same period. Supportive factors and pressure points are offsetting one another.

Margin is nearly flat but the underlying components are moving — this is a transitional phase, more time is needed to see the real trend.

Profitability trend

Net Margin 5.61% +0.2pp
Gross Margin 22.11% +1.1pp
SG&A / Revenue 14.41% +1.6pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Is capital being deployed efficiently?

ROIC edged up to 8.33%, rising 0.7pp. That translates to 8.33 in after-tax operating profit for every 100 units of operating capital. The main driver is capital turnover rose 0.12x — the business is generating more revenue per unit of capital, with NOPAT margin steady; with invested capital holding roughly steady.

Capital efficiency improved through turnover — a positive sign for asset efficiency, but this momentum needs to hold as capital expands.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 8.33% +0.7pp
NOPAT Margin 5.50% +0.0pp
Capital Turnover 1.51x +0.12x
Average Invested Capital 217.6bn −37.8bn

Balance Sheet

Balance sheet is exceptionally sound — liabilities at 0.41x equity, with a net cash position equivalent to 0.17x equity.

Inventory ended the period at 80.4bn, roughly 28.8% of total assets.

Over the last 12 months, working capital released 79.9bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables decreased → higher CFO: +43.2bn
Inventories decreased → higher CFO: +39.9bn
Payables decreased → lower CFO: −3.2bn

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 16.9 days versus the same period last year. The main moves came from DIO fell 34.4 days, DSO rose 9.4 days, and DPO fell 8.1 days.

Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 174.7 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +9.4 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 68.3 days +9.4 days
Inventory 135.4 days −34.4 days
Payables 29.1 days −8.1 days
Cash Conversion Cycle 174.7 days −16.9 days

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 99.8bn.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at -0.17x and interest coverage at 6.16x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 210.5% of debt, and total debt stands at 30.9bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity -0.17x −0.58x
Interest Coverage 6.16x +1.95x
Cash / Debt 210.5% +192.9pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI 6.09x +5.71x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 99.8bn in 2025, against investing cash flow of -0.6bn.

Post-investment cash flow was positive +99.2bn. Financing cash flow was negative +73.3bn.

CFO / net income was 6.09x.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 112.7bn +105.3bn
Cash Capex
FCF TTM

Investment Takeaway

The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. Even so, cash generation still needs confirmation remains the area to verify in upcoming periods. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 175 days.

Improvement: earnings conversion looks more confirmed, with CFO / net income at 6.09x.

Watchpoint: Cash generation still needs confirmation.

Key risk: working capital remains tied up for too long, with cash cycle at 174.7 days.

Statement Data

Item 2025 2024 2023 2022
Net Revenue
317.0 364.1 372.6 297.1
Cost of Goods Sold
250.5 286.2 284.9 227.9
Gross Profit
66.4 77.9 87.7 69.2
Financial Expenses
4.3 6.0 8.0 6.7
Selling Expenses
12.8 12.3 14.2 16.4
General and Administrative Expenses
34.7 31.2 28.5 25.7
Operating Profit
15.0 28.6 37.0 20.6
Profit Before Tax
15.2 29.0 37.7 21.4
Net Income
12.8 23.1 30.6 18.2
Profit Attributable to Parent
12.8 23.1 30.6 18.2
Earnings per Share
1,334.00 2,770.00 4,219.00 2,874.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.